Two Biotechnology Companies Successfully Raise $385 Million in Combined IPOs, Breaking the Dry Spell
The IPO market has been slow this year, but Apogee Therapeutics and Sagimet Biosciences have managed to attract investor confidence and increase the size of their stock offerings. Apogee raised $300 million in its IPO and plans to stand out in the crowded field of immunology and inflammation drugs by offering a dosing advantage. The […]